A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Clinical trial NCT07024615 · RECRUITING
Trial details
- NCT number
- NCT07024615
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-16
- Primary completion
- 2028-01-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.